Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 28,094,936	$ 10,261,671
Prepaid assets and other current assets	1,092,462	12,065
Total current assets	29,187,398	10,273,736
Deferred offering costs		127,768
Total assets	29,187,398	10,401,504
Current liabilities:
Accounts payable	410,638	428,645
Accrued dividends payable		728,350
Total current liabilities	410,638	1,156,995
Accrued research and development expense (see Note 5)	1,132,013
Total liabilities	1,542,651	1,156,995
Commitments and contingencies (see Note 4)
Series A Preferred Stock:
Series A Preferred Stock, $0.001 par value, 10,000,000 shares authorized; 0 and 5,662,000 shares issued and outstanding as of December 31, 2019 and 2018, respectively		12,485,971
Stockholders' equity (deficit):
Common stock; $0.001 par value, 45,000,000 shares authorized; 18,450,992 and 4,000,000 shares issued and outstanding as of December 31, 2019 and 2018, respectively	18,451	4,000
Additional paid-in capital	43,338,710	596,724
Accumulated deficit	(15,712,414)	(3,842,186)
Total stockholders' equity (deficit)	27,644,747	(3,241,462)
Total liabilities, Series A Preferred Stock and stockholders' equity (deficit)	$ 29,187,398	$ 10,401,504